Psyence Biomedical (PBM) Cash & Current Investments (2023 - 2025)

Psyence Biomedical's Cash & Current Investments history runs 3 years deep, the most recent figure standing at $7.2 million for Q3 2025.

• In Q3 2025, Cash & Current Investments rose 266.8% year-over-year to $7.2 million; the TTM figure through Sep 2025 stood at $7.2 million (up 266.8% YoY), while the FY2025 annual figure was $6.2 million, up 709.01% from the prior year.
• Cash & Current Investments was $7.2 million for Q3 2025 at Psyence Biomedical, up from $6.2 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $7.2 million in Q3 2025 to a low of $762799.0 in Q1 2024.
• Historically, Cash & Current Investments has averaged $3.5 million across 3 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 44.07% in 2024, then jumped 709.01% in 2025.
• A 3-year view of Cash & Current Investments shows it stood at $1.4 million in 2023, then soared by 43.87% to $2.0 million in 2024, then jumped by 266.8% to $7.2 million in 2025.
• The last three Cash & Current Investments figures came in at $7.2 million (Q3 2025), $6.2 million (Q1 2025), and $2.0 million (Q3 2024), per Business Quant data.